Pacira Pharmaceuticals (PCRX) PT Lifted to $136 at Piper Jaffray

February 25, 2015 9:49 AM

Piper Jaffray analyst David Amsellem reiterated an Overweight rating and bumped his price target on Pacira Pharmaceuticals (NASDAQ: PCRX) to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found